Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants - Gabe - 2024 - Diabetes, Obesity and Metabolism US$ 25.77 Min. order: 1 piece ★★★★★ 4.8 (61 reviews) Sold : Login>>
CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 25.39 Min. order: 1 piece ★★★★★ 4.9 (51 reviews) Sold : Login>>
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 27.41 Min. order: 1 piece ★★★★★ 4.2 (148 reviews) Sold : Login>>
DSIP (Delta Sleep-Inducing Peptide) US$ 23.33 Min. order: 1 piece ★★★★★ 4.7 (180 reviews) Sold : Login>>
Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models US$ 29.30 Min. order: 1 piece ★★★★★ 4.5 (210 reviews) Sold : Login>>